DeanMWingerchukMD

Neuroimmunology/Multiple Sclerosis

"Professor of Neurology at Mayo Clinic, and Chair of the Mayo Clinic Division of Multiple Sclerosis (MS) and Autoimmune Neurology in Scottsdale Mayo Medical School"

Join to view full profile

Dr. Wingerchuk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wingerchuk's full profile

Already have an account?

Office
13400 E Shea Blvd
Scottsdale, AZ 85259
Phone+1 480-301-8000

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1994 - 1997
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 1993 - 1994
University Saskatchewan Royal HospitalClass of 1993

Certifications & Licensure

NH State Medical License 2015 - Present
AZ State Medical License 1997 - 2026
MN State Medical License 1994 - 2025
NV State Medical License 2015 - 2017
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
Completed
Phase 2
Maintenance Plasma Exchange for Neuromyelitis Optica Start of enrollment: 2012 Jun 01
Completed

Publications & Presentations

PubMed

3 citations
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk
The Lancet. Neurology. 2024-06-01
1 citations
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes.
Edgar Carnero Contentti, Dean M Wingerchuk
Multiple Sclerosis. 2024-01-01
12 citations
Cerebral enhancement in MOG antibody-associated disease.
Paul Elsbernd, Laura Cacciaguerra, Karl N Krecke, John J Chen, David Gritsch
Journal of Neurology, Neurosurgery, and Psychiatry. 2023-12-14

Press Mentions

Careful Evaluation, Genetic Testing Offer a New Path ForwardFebruary 10th, 2020
Estudo Mostra Que Droga Reduz Risco De Recaída Da Neuromielite ÓpticaMay 16th, 2019
Drug Reduces Risk of Relapse with Neuromyelitis OpticaMay 6th, 2019
Join now to see all